Dr. Robert A. Kornfeld Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor
November 02 2017 - 11:00AM
Access Wire
HICKSVILLE, NY / ACCESSWIRE / November 2, 2017
/ Canbiola, Inc. (OTC PINK: CANB), in its continuing
effort to partner with the top people in the Global Health and
Wellness field, announced today that the company has added Dr.
Robert A. Kornfeld to its Medical Advisory Board. Dr. Kornfeld was
also signed as a distributor for Canbiola products. Dr. Kornfeld
will utilize and distribute Canbiola products through The Chronic
Foot Pain Center. The Chronic Foot Pain Center specializes in
patients with chronic foot and ankle pain who have been failed by
traditional medicine and surgery, as well as those patients seeking
a more natural approach to their health care. Dr. Kornfeld stated,
"It's very important to me to join forces with a company that
produces and distributes only the highest quality products with the
patient in mind. Canbiola is just that company. They offer numerous
CBD products in pure and different forms that answer the needs of
the public. As a doctor, I am committed to helping my patients
avoid potentially harmful drugs and to help them heal naturally.
Canbiola's CBD products have many applications in medicine and will
surely help many of my patients."
Marco Alfonsi, Canbiola CEO, stated, "We are continuing to
execute our plan to strengthen not only our Medical Advisory Board,
but also our distribution network. With the addition of Dr.
Kornfeld, we have added our ability to reach a holistic healing
market for our products. The company has already seen the benefits
of this strategy with better than expected results from previously
added medical advisors and have no doubt that this last addition
will further grow both sales and geographically expand our client
base."
Canbiola will be attending the Navel Expo, November 4-5, at the
Sheraton Times Square, where Dr. Kornfeld will be speaking.
Canbiola will have a booth where attendees can learn more about the
benefits of CBD and see their products.
About Dr. Robert A. Kornfeld
Dr. Robert A. Kornfeld, the first holistic oriented podiatrist
in the U.S., has been practicing integrative and functional
medicine for chronic foot and ankle pain for over 35 years. Dr.
Kornfeld has developed protocols for all foot and ankle pathology
that assist the body in achieving improved health while he
eliminates the chronic pain syndrome. Dr. Kornfeld is an expert in
homeopathic injection therapy, prolotherapy, platelet-rich-plasma
injections, amniotic fluid injections, nutritional and herbal
medicine, lower extremity biomechanics, and functional
medicine.
The Chronic Foot Pain Center specializes in patients with
chronic foot and ankle pain who have been failed by traditional
medicine and surgery, as well as those patients seeking a more
natural approach to their health care.
Dr. Kornfeld is Board Certified in Integrative Medicine by the
American Association of Integrative Medicine and is a Diplomate of
the College of Physicians, AAIM.
Dr. Kornfeld has lectured extensively throughout the country,
has hosted his own radio shows in NYC, has been featured on local
TV shows and is the Founder of The Institute for Integrative
Podiatric Medicine. He is a former Assistant Professor - New York
College of Podiatric Medicine - Dept. of Integrative Medicine.
Certifications:
- Fellow - American College of Alternative Medicine
- Board Certified - American Association of Integrative
Medicine
- Diplomate-College of Physicians - American Association of
Integrative Medicine
- Diplomate - American Board of Alternative Medicine
- Diplomate - American Alternative Medical Association
- Board Certified - International Society of Homotoxicology
APPOINTMENTS:
- Director - Post-Graduate Preceptorship in Podiatric Medicine
and Surgery at Mt. Hope Medical Center - Bronx, N.Y. 1982-1987
- Director - Holistic & Complementary Podiatric Medicine, LLC
- 1997 - present
- Former Adjunct Assistant Professor – New York College of
Podiatric Medicine - Dept. of Integrative Medicine
- Founder - Institute for Integrative Podiatric Medicine -
2008
About Canbiola, Inc.
Canbiola, Inc. is a public company trading under symbol CANB.
The company's focus is in the sale of a variety of Cannabidiol
(CBD)-based products derived from legally imported hemp. Canbiola
is in the process of developing its own line of proprietary
products as well as seeking synergistic value through acquisitions
in the CBD and the medical cannabis industry. The company has
already launched several products found at www.canbiola.com.
Cannabis is currently federally illegal and has been legalized for
medical purposes in varying forms in only a limited number of
states.
The company also owns two technological solutions, "WRAPmail"
(US Patent 8,572,275), which turns traditional email into a
powerful marketing and branding tool, and "Prosperity Systems" and
the "Bullseye" platform of document management and compliance
targeted at broker-dealers, public companies, and governmental
agencies providing a flawless all-in-one solution for document
management, retention and compliance.
Forward-Looking Statements and Risks and
Uncertainties
Matters discussed in this press release contain forward-looking
statements. The words "anticipate," "believe," "estimate," "may,"
"intend," "expect," and similar expressions identify such
forward-looking statements. Expected results, actual results,
performance, or achievements could differ materially from those
contemplated, expressed, or implied by the forward-looking
statements contained herein. Forward-looking statements are subject
to a number of risks and uncertainties, including but not limited
to, risks and uncertainties associated with, among other things,
the impact of economic, competitive, and other factors affecting
our operations, markets, products, and performance. The matters
discussed herein should not be construed in any way, shape or
manner of our future financial condition or stock price. We do not
undertake to update any statement should actual result differ from
the forward-looking statement.
For a complete information regarding our business, find more
here: Canbiola.
Twitter
Facebook
Canbiola Investor Relations
IR@canbiola.com
Phone (516) 595-9544
http://www.canbiola.com
SOURCE: Canbiola Inc.
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Feb 2024 to Mar 2024
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Mar 2023 to Mar 2024